The role of extracellular volume fraction in predicting left ventricular reverse remodelling and adverse outcomes in patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fraction

Chung, B.K. and Ling, Hwei Sung and Chan, En Ze and Thien, L.K. and Pang, I. X. and LEONG, L. K. and CHIANG, K. H. and Ko, A. T. Y. and Khor, H. K. and Shu, F.E.P. and Ho, K.H. and Chow, H.B. and Tan, C.T. and Koh, K.T. and Oon, Y.Y. and Asri, Said and Fong, A.Y.Y. and Ong, T.K. and Cham, Y.L. (2023) The role of extracellular volume fraction in predicting left ventricular reverse remodelling and adverse outcomes in patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fraction. International Journal of Cardiology, 393 (Supp.). p. 6. ISSN 0167-5273

PDF role.pdf Download (149kB)

Abstract

Cardiac magnetic resonance (CMR) permits the quantification of extracellular volume fraction (ECV) which is a surrogate marker of myocardial interstitial fibrosis. ECV has been shown to predict heart failure (HF) events. Conversely, left ventricular reverse remodelling (LVRR) defined as decrease in chamber volumes and improvement in function, has a positive impact on prognosis. In patients with non-ischemic cardiomyopathy (NICM), the role of ECV in LVRR is not established.

Actions (For repository members only: login required)

View Item